These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3038785)

  • 21. [Effect of euphylline on the cyclic nucleotide content and cAMP phosphodiesterase activity of the lymphocytes of bronchial asthma patients].
    Ialkut SI; Kotov SA; Berezhnoĭ KM
    Farmakol Toksikol; 1984; 47(1):74-7. PubMed ID: 6323215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as anti-inflammatory drugs.
    Spina D; Landells LJ; Page CP
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():24-34. PubMed ID: 9756183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma cyclic AMP level and cAMP phosphodiesterase activity in Takayasu's disease (author's transl)].
    Nlmano F; Kochi K; Arita M; Tamaki H; Numano F
    Nihon Naika Gakkai Zasshi; 1976 Oct; 65(10):1020-5. PubMed ID: 12238
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
    Dastidar SG; Rajagopal D; Ray A
    Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis.
    Chan SC; Reifsnyder D; Beavo JA; Hanifin JM
    J Allergy Clin Immunol; 1993 Jun; 91(6):1179-88. PubMed ID: 8389777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of atopic dermatitis].
    Schöpf E; Kapp A
    Immun Infekt; 1985 Sep; 13(5):179-83. PubMed ID: 2998974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of leukocyte cyclic AMP phosphodiesterase activity by recombinant interferon-gamma: evidence for a differential effect on atopic monocytes.
    Li SH; Chan SC; Kramer SM; Hanifin JM
    J Interferon Res; 1993 Jun; 13(3):197-202. PubMed ID: 8396165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis.
    Holden CA; Chan SC; Hanifin JM
    J Invest Dermatol; 1986 Sep; 87(3):372-6. PubMed ID: 3016107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiologic mechanisms in atopic dermatitis.
    Boguniewicz M; Leung DY
    Semin Cutan Med Surg; 2001 Dec; 20(4):217-25. PubMed ID: 11770908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The seasonal rhythm of changes in adenosine cyclic monophosphate phosphodiesterase activity in the lymphocytes of human peripheral blood].
    Kochetkova MN; Ozeretskovskaia NN; Ezhkova NG
    Izv Akad Nauk SSSR Biol; 1988; (5):782-5. PubMed ID: 2849615
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis.
    Sawai T; Ikai K; Uehara M
    Br J Dermatol; 1995 Jan; 132(1):22-4. PubMed ID: 7756148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyclic adenosine 3-5 monophosphate (c-AMP) and allergy].
    Ring J
    Hautarzt; 1978 Dec; 29(12):625-31. PubMed ID: 82550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction.
    Kurokawa Y; Fukuda I; Mozai T
    Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124
    [No Abstract]   [Full Text] [Related]  

  • 36. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis.
    Chan SC; Kim JW; Henderson WR; Hanifin JM
    J Immunol; 1993 Sep; 151(6):3345-52. PubMed ID: 8397256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
    Butler JM; Ebertz M; Chan SC; Stevens SR; Sobieszczuk D; Hanifin JM
    Acta Derm Venereol Suppl (Stockh); 1985; 114():55-60. PubMed ID: 2408432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic adenosine monophosphate-phosphodiesterase activity in cultured keratinocytes from patients with atopic eczema.
    Wright S; Navsaria H; Leigh IM
    J Dermatol Sci; 1991 Jul; 2(4):263-7. PubMed ID: 1655006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
    Delgado M; Fernández-Alfonso MS; Fuentes A
    Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase and immune dysfunction in atopic dermatitis.
    Hanifin JM
    J Dermatol Sci; 1990 Jan; 1(1):1-6. PubMed ID: 1964082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.